Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Intra-Cellular Therapies, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 274
- +8 vs. Q2 2022
- Shares held
- 83.5M
- +2.01M (+2.5%) vs. Q2 2022
- Total value
- $3.89B
- −$766.5M (−16.5%) vs. Q2 2022
- New holders
- 43
- 103 more added
- Sold out
- 35
- 86 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $2.54K |
| Q1 2026 | 1 | $2.54K |
| Q4 2025 | 1 | $2.54K |
| Q3 2025 | 1 | $2.54K |
| Q2 2025 | 4 | $4.15M |
| Q1 2025 | 395 | $13.6B |
| Q4 2024 | 387 | $8.08B |
| Q3 2024 | 356 | $7.12B |
| Q2 2024 | 376 | $6.62B |
| Q1 2024 | 346 | $6.15B |
| Q4 2023 | 335 | $6.42B |
| Q3 2023 | 294 | $4.54B |
| Q2 2023 | 288 | $5.34B |
| Q1 2023 | 274 | $4.55B |
| Q4 2022 | 283 | $4.41B |
| Q3 2022 | 274 | $3.89B |
| Q2 2022 | 266 | $4.65B |
| Q1 2022 | 241 | $4.94B |
| Q4 2021 | 208 | $3.60B |
| Q3 2021 | 181 | $2.56B |
| Q2 2021 | 187 | $2.74B |
| Q1 2021 | 170 | $2.30B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parametrica Management Ltd | 0 | $0 | 0.00% | −4,072−100.0% | Sold out |
| Penbrook Management LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −3,593−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −3,668−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −1,152−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −984−100.0% | Sold out |
| Northern Oak Wealth Management Inc | 0 | $0 | 0.00% | −899−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −367−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |